224 related articles for article (PubMed ID: 12003423)
1. Acute pancreatitis in Soweto, South Africa: relationship between trypsinogen load, trypsinogen activation, and fibrinolysis.
Segal I; Chaloner C; Douglas J; John KD; Zaidi A; Cotter L; Appelros S; Borgström A; Braganza JM
Am J Gastroenterol; 2002 Apr; 97(4):883-92. PubMed ID: 12003423
[TBL] [Abstract][Full Text] [Related]
2. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis.
Appelros S; Petersson U; Toh S; Johnson C; Borgström A
Br J Surg; 2001 Feb; 88(2):216-21. PubMed ID: 11167870
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of the serum carboxypeptidase B activation peptide in acute pancreatitis.
Pezzilli R; Morselli-Labate AM; Barbieri AR; Platè L
JOP; 2000 Sep; 1(3):58-68. PubMed ID: 11854559
[TBL] [Abstract][Full Text] [Related]
4. A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis.
Hedström J; Kemppainen E; Andersén J; Jokela H; Puolakkainen P; Stenman UH
Am J Gastroenterol; 2001 Feb; 96(2):424-30. PubMed ID: 11232685
[TBL] [Abstract][Full Text] [Related]
5. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study.
Khan Z; Vlodov J; Horovitz J; Jose RM; Iswara K; Smotkin J; Brown A; Tenner S
Am J Gastroenterol; 2002 Aug; 97(8):1973-7. PubMed ID: 12190163
[TBL] [Abstract][Full Text] [Related]
6. A loss-of-function p.G191R variant in the anionic trypsinogen (PRSS2) gene in Japanese patients with pancreatic disorders.
Kume K; Masamune A; Takagi Y; Kikuta K; Watanabe T; Satoh K; Satoh A; Hirota M; Hamada S; Shimosegawa T
Gut; 2009 Jun; 58(6):820-4. PubMed ID: 19052022
[TBL] [Abstract][Full Text] [Related]
7. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
8. Early sequential changes in serum markers of acute pancreatitis induced by endoscopic retrograde cholangiopancreatography.
Lempinen M; Stenman UH; Halttunen J; Puolakkainen P; Haapiainen R; Kemppainen E
Pancreatology; 2005; 5(2-3):157-64. PubMed ID: 15849486
[TBL] [Abstract][Full Text] [Related]
9. Protease activation, pancreatic leakage, and inflammation in acute pancreatitis: differences between mild and severe cases and changes over the first three days.
Regnér S; Manjer J; Appelros S; Hjalmarsson C; Sadic J; Borgström A
Pancreatology; 2008; 8(6):600-7. PubMed ID: 18849642
[TBL] [Abstract][Full Text] [Related]
10. What are the predictors of post-ERCP pancreatitis, and how useful are they?
Sultan S; Baillie J
JOP; 2002 Nov; 3(6):188-94. PubMed ID: 12432185
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity.
Van Acker GJ; Saluja AK; Bhagat L; Singh VP; Song AM; Steer ML
Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G794-800. PubMed ID: 12181196
[TBL] [Abstract][Full Text] [Related]
12. Comparison of urine trypsinogen-2 test strip with serum lipase in the diagnosis of acute pancreatitis.
Kylänpää-Bäck ML; Kemppainen E; Puolakkainen P; Hedström J; Haapiainen R; Korvuo A; Stenman UH
Hepatogastroenterology; 2002; 49(46):1130-4. PubMed ID: 12143219
[TBL] [Abstract][Full Text] [Related]
13. Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide.
Liu ZS; Jiang CQ; Qian Q; Sun Q; Fan LF; Ai ZL
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):285-9. PubMed ID: 14612286
[TBL] [Abstract][Full Text] [Related]
14. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.
Johnson CD; Lempinen M; Imrie CW; Puolakkainen P; Kemppainen E; Carter R; McKay C
Br J Surg; 2004 Aug; 91(8):1027-33. PubMed ID: 15286966
[TBL] [Abstract][Full Text] [Related]
15. Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis.
Lempinen M; Stenman UH; Finne P; Puolakkainen P; Haapiainen R; Kemppainen E
J Surg Res; 2003 May; 111(2):267-73. PubMed ID: 12850473
[TBL] [Abstract][Full Text] [Related]
16. Mechanism and role of trypsinogen activation in acute pancreatitis.
Mayer J; Rau B; Schoenberg MH; Beger HG
Hepatogastroenterology; 1999; 46(29):2757-63. PubMed ID: 10576341
[TBL] [Abstract][Full Text] [Related]
17. The cumulative effect of nuclear factor-kappaB (NF-kappaB) inhibition and endothelins in early cerulein-induced acute pancreatitis in rats.
Długosz JW; Andrzejewska A; Nowak K; Wróblewski E; Dabrowski A
Rocz Akad Med Bialymst; 2005; 50():230-6. PubMed ID: 16358973
[TBL] [Abstract][Full Text] [Related]
18. The effect of endothelin-1, endothelin-2 and endothelin-3 in early cerulein-induced acute pancreatitis in rats.
Długosz JW; Nowak K; Andrzejewska A; Wróblewski E; Dabrowski A
Rocz Akad Med Bialymst; 2004; 49():85-92. PubMed ID: 15631320
[TBL] [Abstract][Full Text] [Related]
19. Reliable screening for acute pancreatitis with rapid urine trypsinogen-2 test strip.
Kylänpää-Bäck M; Kemppainen E; Puolakkainen P; Hedström J; Haapiainen R; Perhoniemi V; Kivilaakso E; Korvuo A; Stenman U
Br J Surg; 2000 Jan; 87(1):49-52. PubMed ID: 10606910
[TBL] [Abstract][Full Text] [Related]
20. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
